← Back to Search

RKP Monitoring Software for Ventilator-Associated Events

N/A
Recruiting
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects requiring invasive mechanical ventilation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve care for patients on ventilators by using a software system called Vyaire's Respiratory Knowledge Portal (RKP). The system collects data on ventilator-associated events (VA

Who is the study for?
This trial is for patients in the ICU who require mechanical ventilation due to various respiratory failures and conditions. It aims to improve their care by reducing complications associated with ventilators.
What is being tested?
The Respiratory Knowledge Portal (RKP) Monitoring Software is being tested. This software collects data on ventilator use, aiming to enhance patient outcomes by adhering to best practice protocols more closely.
What are the potential side effects?
Since this trial involves a monitoring software rather than a medication, traditional side effects are not applicable. However, there may be risks related to data privacy or potential reliance on technology over clinical judgment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need a machine to help me breathe.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Duration of Days on mechanical ventilation
Number of Ventilator Alarm Set Outside of Compliance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
We will monitor without clinician use of the software.
Group II: Use of RKPActive Control1 Intervention
Use of RKP alerts to the standard of care.

Find a Location

Who is running the clinical trial?

The University of Texas Medical Branch, GalvestonLead Sponsor
254 Previous Clinical Trials
56,916 Total Patients Enrolled
Vyaire MedicalIndustry Sponsor
10 Previous Clinical Trials
1,024 Total Patients Enrolled
~178 spots leftby Mar 2025